Cargando…
Novel Antifungal Compounds Discovered in Medicines for Malaria Venture’s Malaria Box
Similarities in fungal and animal cells make antifungal discovery efforts more difficult than those for other classes of antimicrobial drugs. Currently, there are only three major classes of antifungal drugs used for the treatment of systemic fungal diseases: polyenes, azoles, and echinocandins. Eve...
Autores principales: | Jung, Eric H., Meyers, David J., Bosch, Jürgen, Casadevall, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853493/ https://www.ncbi.nlm.nih.gov/pubmed/29564402 http://dx.doi.org/10.1128/mSphere.00537-17 |
Ejemplares similares
-
Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever
por: Nyagwange, James, et al.
Publicado: (2019) -
Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture’s Pathogen Box
por: Wall, Gina, et al.
Publicado: (2019) -
Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
por: Tadele, Markos, et al.
Publicado: (2020) -
A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box
por: Jumani, R. S., et al.
Publicado: (2018) -
Identification of an Atg8-Atg3 Protein–Protein
Interaction Inhibitor from the Medicines for Malaria Venture Malaria
Box Active in Blood and Liver Stage Plasmodium falciparum Parasites
por: Hain, Adelaide U.P., et al.
Publicado: (2014)